Policy changes Backwork has recorded, newest first. The most recent change on record is from October 14, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
83,427 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| Aug 2, 2026 | EviCore by Evernorth | Cosentyx Intravenous (secukinumab) | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Corifact (factor XIII concentrate [human]) Tretten (coagulation factor XIII A-subunit [recombinant]) | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Collagenase clostridium histolyticum (Xiaflex) | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Collagenase clostridium histolyticum (Xiaflex) | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Collagenase clostridium histolyticum (Xiaflex) | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Collagenase Clostridium Histolyticum (Xiaflex) | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Collagenase clostridium histolyticum (Xiaflex) | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Collagenase clostridium histolyticum (Xiaflex) | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Coagulation Factor VIIa (recombinant)-jncw [Sevenfact] | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Coagadex (coagulation factor X [Human]) | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Clinical Information to Establish Medical Necessity | New policy |
| Aug 2, 2026 | EviCore by Evernorth | Clinical Information to Establish Medical Necessity | New policy |
| Aug 2, 2026 | EviCore by Evernorth | Cinryze (C1 esterase inhibitor [human]) | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Cinryze (C1 esterase inhibitor [human]) | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Cinqair (reslizumab) | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Cinqair (reslizumab) | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Cerezyme (imiglucerase) | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Cerezyme (imiglucerase) | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Casimersen Intravenous Infusion (Amondys 45) - Medicaid TX | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Casimersen Intravenous Infusion (Amondys 45) | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Casimersen Intravenous Infusion (Amondys 45) | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Casimersen Intravenous Infusion (Amondys 45) | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Caplacizumab-yhdp (Cablivi) | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Caplacizumab-yhdp (Cablivi) | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Caplacizumab-yhdp (Cablivi) | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Caplacizumab-yhdp (Cablivi) | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Caplacizumab-yhdp (Cablivi) | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Canakinumab (Ilaris) | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Canakinumab (Ilaris) | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Canakinumab (Ilaris) | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Canakinumab (Ilaris) | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Canakinumab (Ilaris) | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Canakinumab (Ilaris) | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Cabotegravir and Rilpivirine (Cabenuva) | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Cabotegravir and Rilpivirine (Cabenuva) | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Cabotegravir and Rilpivirine (Cabenuva) | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Cabotegravir (Apretude) | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Cabotegravir (Apretude) | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Cablivi (caplacizumab-yhdp) | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Cablivi (caplacizumab-yhdp) | New policy |
| Aug 2, 2026 | EviCore by Evernorth | Cablivi (caplacizumab-yhdp) | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Cabenuva (cabotegravir and rilpivirine extended-release injectable suspension) | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Cabenuva (cabotegravir and rilpivirine extended-release injectable suspension) | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | C1 Esterase Inhibitor (Ruconest) | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | C1 Esterase Inhibitor (Ruconest) | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | C1 Esterase Inhibitor (Ruconest) | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | C1 Esterase Inhibitor (Ruconest) | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | C1 Esterase Inhibitor (Ruconest) | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | C1 Esterase Inhibitor (Cinryze) | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | C1 Esterase Inhibitor (Cinryze) | Metadata changed |